연구동향 분석

염증질환으로서의 우울증

송후림 우영섭 박원명 2013년

논문상세정보
인용/피인용
' 염증질환으로서의 우울증' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 임상의학
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
2,361 3

0.0%

' 염증질환으로서의 우울증' 의 참고문헌

  • Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load
    Neuron 73 : 219 ~ 234 [2012]
  • The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression
    J Affect Disord 49 : 211 ~ 219 [1998]
  • The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis
    Neuropsychopharmacology 36 : 2452 ~ 2459 [2011]
  • The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
    Mol Psychiatry 11 : 680 ~ 684 [2006]
  • The HPA-axis and immune function in burnout
    Prog Brain Res 167 : 281 ~ 285 [2008]
  • TNF-alpha as a molecular target in bipolar disorder
    Prog Neuropsychopharmacol Biol Psychiatry 32 : 1355 ~ 1361 [2008]
  • Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features
    Psychiatry Res 198 : 74 ~ 80 [2012]
  • Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety
    Stress 8 : 209 ~ 219 [2005]
  • Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder
    J Affect Disord 120 : 245 ~ 248 [2010]
  • Raised CRP levels in obese patients: symptoms of depression have an independent positive association
    Obesity 16 : 2010 ~ 2015 [2008]
  • Paroxetine for the prevention of depression induced by high-dose interferon alfa
    N Engl J Med 344 : 961 ~ 966 [2001]
  • Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder
    Psychol Med 2012 : 1 ~ 9 [2012]
  • Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions
    Neuropsychopharmacology 26 : 643 ~ 652 [2002]
  • Microvascular pathology in late-life depression
    J Neurol Sci 322 : 46 ~ 49 [2012]
  • Is depression an inflammatory disorder?
    Curr Psychiatry Rep 13 : 467 ~ 475 [2011]
  • Inflammation, glutamate, and glia in depression: a literature review
    CNS Spectr 13 : 501 ~ 510 [2008]
  • Inflammation and depression: is there a causal connection with dementia?
    Neurotox Res 10 : 149 ~ 160 [2006]
  • Inflammation and Depression
    Curr Top Behav Neurosci [2012]
  • Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection
    Viral Immunol 18 : 41 ~ 78 [2005]
  • Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio
    Acta Psychiatr Scand 86 : 423 ~ 431 [1992]
  • HPA and immune axes in stress: involvement of the serotonergic system
    Neuroimmunomodulation 13 : 268 ~ 276 [2006]
  • Glutamatergic modulators: the future of treating mood disorders?
    Harv Rev Psychiatry 18 : 293 ~ 303 [2010]
  • Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment
    Mol Psychiatry 14 : 1095 ~ 1104 [2009]
  • Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer’s disease
    J Neuroinflammation 6 : 36 ~ [2009]
  • Depression: an inflammatory illness?
    J Neurol Neurosurg Psychiatry 83 : 495 ~ 502 [2012]
  • Cytokines, stress and depressive illness: brain-immune interactions
    Ann Med 35 : 2 ~ 11 [2003]
  • Cytokines and the brain:implications for clinicalpsychiatry
    교육과학기술부 Am J Psychiatry 157 : 683 ~ 694 [2000]
  • Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis
    Biol Psychiatry 71 : 15 ~ 21 [2012]
  • Corticotropin-releasing hormone receptor antagonists: an update
    Endocr Dev 17 : 36 ~ 43 [2010]
  • Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat
    Prog Neuropsychopharmacol Biol Psychiatry 39 : 143 ~ 148 [2012]
  • Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
    Hum Psychopharmacol 23 : 87 ~ 94 [2008]
  • Can inflammation be an independent predictor of depression?
    Brain Behav Immun 24 : 173 ~ [2010]
  • C reactive protein in women with coronary heart disease and its association with depression
    Z Psychosom Med Psychother 58 : 158 ~ 172 [2012]
  • Brain-immune interactions and implications in psychiatric disorders
    Rev Bras Psiquiatr 29 (suppl 1) : S27 ~ S32 [2007]
  • Associations of anti-hypertensive treatments with Alzheimer’s disease, vascular dementia, and other dementias
    J Alzheimers Dis 26 : 699 ~ 708 [2011]
  • Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression
    Mol Psychiatry [2012]
  • Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans
    Proc Natl Acad Sci U S A 108 : 9262 ~ 9267 [2011]
  • Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression
    Biol Psychiatry 65 : 296 ~ 303 [2009]
  • Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats
    Neurosci Lett 499 : 74 ~ 79 [2011]
  • A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
    Hum Psychopharmacol 25 : 201 ~ 215 [2010]
  • A meta-analysis of cytokines in major depression
    Biol Psychiatry 67 : 446 ~ 457 [2010]
  • A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase
    Neuropsychiatr Dis Treat 7 : 431 ~ 439 [2011]